Search Results - "Vigna, Leonardo"

PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy by Cognetti, Francesco, Masetti, Riccardo, Fabi, Alessandra, Bianchi, Giulia, Santini, Donatella, Rognone, Alessia, Catania, Giovanna, Angelucci, Domenico, Naso, Giuseppe, Giuliano, Mario, Vassalli, Lucia, Vici, Patrizia, Scognamiglio, Giovanni, Generali, Daniele, Zambelli, Alberto, Colleoni, Marco, Tinterri, Corrado, Scanzi, Francesco, Vigna, Leonardo, Scavina, Paola, Gamucci, Teresa, Marrazzo, Emilia, Scinto, Angelo Fedele, Berardi, Rossana, Fabbri, Maria Agnese, Pinotti, Graziella, Franco, Daniela, Terribile, Daniela Andreina, Tonini, Giuseppe, Cianniello, Daniela, Barni, Sandro

“…Clinicopathological prognostic features have limited value to identify with precision newly diagnosed patients with hormone receptor (HR)-positive,…”
Get full text

Cavernous Hemangioma: A Potential Pitfall at Delayed 18F-FDG PET/CT Scan by Scolozzi, Valentina, Giancipoli, Romina Grazia, Macciomei, Maria Cristina, Vigna, Leonardo, Leccisotti, Lucia

“…We report the case of a 72-year-old woman who underwent neoadjuvant chemotherapy, right quadrantectomy (invasive ductal carcinoma, G3, pT2pN1pMx), and adjuvant…”
Get full text

Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT Trials by Rossi, Valentina, Berchialla, Paola, Giannarelli, Diana, Nisticò, Cecilia, Ferretti, Gianluigi, Gasparro, Simona, Russillo, Michelangelo, Catania, Giovanna, Vigna, Leonardo, Mancusi, Rossella Letizia, Bria, Emilio, Montemurro, Filippo, Cognetti, Francesco, Fabi, Alessandra

“…: We aim to understand whether all patients with hormonal receptor (HR)-positive (+)/human epidermal growth factor receptor-2 (HER2)-negative (-) metastatic…”
Get full text

Cavernous Hemangioma: A Potential Pitfall at Delayed 18F-FDG PET/CT Scan by Scolozzi, Valentina, Giancipoli, Romina Grazia, Macciomei, Maria Cristina, Vigna, Leonardo, Leccisotti, Lucia

Get full text

Molecular characterization of a selected cohort of patients affected by pulmonary metastases of malignant melanoma: Hints from BRAF, NRAS and EGFR evaluation by Ulivieri, Alessandra, Cardillo, Giuseppe, Manente, Liborio, Paone, Gregorino, Mancuso, Andrea Petricca, Vigna, Leonardo, Di Stasio, Enrico, Gasbarra, Rita, Girlando, Salvatore, Leone, Alvaro

“…Melanoma is highly curable in early stages but holds devastating consequences in advanced phases with a median survival of 6-10 months. Lungs are a common…”
Get full text

Analysis of BRAF , NRAS , cKIT, and EGFR alterations in melanoma lung metastases by Ulivieri, Alessandra, Cardillo, Giuseppe, Manente, Liborio, Mancuso, Andrea Petricca, Vigna, Leonardo, Gasbarra, Rita, Leone, Alvaro

“…Abstract only e19033 Background: About 25% of pts will eventually develop lung metastases from primary melanoma. Activating mutations in BRAF, NRAS, CKIT and…”
Get full text

Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti‐angiogenic treatment by Mancuso, Andrea, Di Paola, Eugenio Donato, Leone, Alvaro, Catalano, Alfonso, Calabrò, Fabio, Cerbone, Linda, Zivi, Andrea, Messina, Carlo, Alonso, Silvia, Vigna, Leonardo, Caristo, Rita, Sternberg, Cora N.

“…Study Type – Therapy (individual cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Sorafenib is an oral receptor tyrosine…”
Get full text

Helical tomotherapy: an innovative radiotherapy technique for the treatment of locally advanced oropharynx and inoperable oral cavity carcinoma by Donato, Vittorio, Cianciulli, Michele, Fouraki, Sofia, Vigna, Leonardo, Rocco, Alberto, Raffetto, Nicola, Bellocchi, Gianluca

“…To report our initial clinical experience of helical tomotherapy (HT) in the treatment of locally advanced oropharynx and inoperable oral cavity cancer…”
Get full text